rty Review: "Sanofi unit takes CSL to court over haemophilia therapy," Sarah Morgan, March 05, 2020, 8:00 AM Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B drug Alprolix (coagulation factor IX (Recombinant), Fc fusion protein). In its suit, filed y